TIRZEPATIDE OVERVIEW Category: Dual GIP and GLP-1 Receptor Agonist How It Works: Tirzepatide selectively activates both the GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-like Peptide 1) receptors, a dual agonism that provides synergistic benefits
Personalized Supplementation With PlexusDx Precision Testing PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway assessment that reveals your individual predispositions across 14 metabolic pathways and 49 key peptides
High-density miniaturized thermal shift assays as a general strategy for drug discovery
Severe obesity nearly claimed Linda Browns life In just two months, I lost 80 pounds, my blood pressure improved, and I finally felt energetic again. Linda Brown, Seattle, USA A congenital heart defect prevents me from exercising After just 2-3 weeks, I started losing weight and my energy soared! Thomas Fitzpatrick, Portland, USA Swollen lymph nodes bothered me for years After just a few days using Cvreoz, the swelling subsided. Victoria Anastasia, Victoria, USA Targeting Root Causes Poor lymphatic circulation, insulin resistance, and hormonal imbalances
Before asking for a dose increase, stick with your current dose for at least four weeks to confirm the plateau is real
